货号 |
中文名称 |
英文名词 |
靶点 |
VAPD00154 |
罗妥木单抗
|
Research Grade Robatumumab Biosimilar |
IGF1R, CD221 |
VAPD00153 |
Research Grade burfiralimab Biosimilar
|
Research Grade burfiralimab Biosimilar |
VIM, Vimentin |
VAPD00152 |
硫索单抗
|
Research Grade sulesomab Biosimilar |
CEACAM6, NCA, CD66c |
VAPD00151 |
阿塞珠单抗
|
Research Grade Aselizumab Biosimilar |
CD62L |
VAPD00150 |
普林木单抗
|
Research Grade Pritumumab Biosimilar |
VIM, Vimentin |
VAPD00149 |
比伐珠单抗
|
Research Grade Bivatuzumab Biosimilar |
CD44 |
VAPD00148 |
帕他莫单抗
|
Research Grade Taplitumomab Biosimilar |
CD19 |
VAPD00147 |
来马索单抗
|
Research Grade Lemalesomab Biosimilar |
CEACAM6, NCA, CD66c |
VAPD00146 |
厄利珠单抗
|
Research Grade Erlizumab Biosimilar |
ITGB2, CD18, MFI7, Integrin beta-2 |
VAPD00145 |
伐利昔单抗
|
Research Grade Vapaliximab Biosimilar |
AOC3, VAP1, SSAO,Vascular adhesion protein 1 |